3T BIOSCIENCES

3t-biosciences-logo

Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.

#SimilarOrganizations #People #Financial #Website #More

3T BIOSCIENCES

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2017-01-01

Address:
Menlo Park, California, United States

Country:
United States

Website Url:
http://www.3tbiosciences.com

Total Employee:
11+

Status:
Active

Total Funding:
52 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

stefan-scherer_image

Stefan Scherer
Stefan Scherer CEO and President @ 3T Biosciences
CEO and President
2021-01-01

marvin-gee_image

Marvin Gee
Marvin Gee Co-Founder, Head of Target Discovery @ 3T Biosciences
Co-Founder, Head of Target Discovery
2017-02-01

leah-sibener_image

Leah Sibener
Leah Sibener Co-founder, Head of Therapeutic Discovery @ 3T Biosciences
Co-founder, Head of Therapeutic Discovery
2019-03-01

Founder


leah-sibener_image

Leah Sibener

luke-lee_image

Luke Lee

marvin-gee_image

Marvin Gee

Investors List

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series A - 3T Biosciences

westlake-village-biopartners_image

Westlake Village BioPartners

Westlake Village BioPartners investment in Series A - 3T Biosciences

os-fund_image

OS Fund

OS Fund investment in Seed Round - 3T Biosciences

crvvc_image

CRV

CRV investment in Seed Round - 3T Biosciences

menlo-ventures_image

Menlo Ventures

Menlo Ventures investment in Seed Round - 3T Biosciences

sean-parker_image

Sean Parker

Sean Parker investment in Seed Round - 3T Biosciences

starlight-ventures-management-llc_image

Starlight Ventures

Starlight Ventures investment in Seed Round - 3T Biosciences

thiel-capital_image

Thiel Capital

Thiel Capital investment in Seed Round - 3T Biosciences

asset-management-ventures_image

Asset Management Ventures (AMV)

Asset Management Ventures (AMV) investment in Seed Round - 3T Biosciences

asset-management-ventures_image

Asset Management Ventures (AMV)

Asset Management Ventures (AMV) investment in Convertible Note - 3T Biosciences

Official Site Inspections

http://www.3tbiosciences.com Semrush global rank: 9.76 M Semrush visits lastest month: 112

  • Host name: 104.21.52.33
  • IP address: 104.21.52.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "3T Biosciences"

About - 3T Biosciences

Putting it all together. Our proprietary 3T-TRACE TM platform technology revolutionizes target discovery and therapeutic development, by taking โ€ฆSee details»

3T Biosciences - Overview, News & Similar companies - ZoomInfo

Dec 16, 2020 Who is 3T Biosciences. 3T Biosciences is an immunotherapy company based in South San Francisco. The company's 3T-TRACE technology applies a yeast display platform โ€ฆSee details»

Team - 3T Biosciences

Tact, Transparency, and Trust are the three pillars of 3T Biosciences culture. These three pillars are key to our strong focus on empowering each 3T colleague to focus on building the strength โ€ฆSee details»

3T Biosciences - Crunchbase Company Profile & Funding

3T Biosciences is an immunotherapy company headquartered in Menlo Park, California. View contacts for 3T Biosciences to access new leads and connect with decision-makers.See details»

3T Biosciences - LinkedIn

3T Biosciences Biotechnology Research South San Francisco, California 4,752 followers 3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations.See details»

3T BIOSCIENCES INC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for 3T BIOSCIENCES INC of Menlo Park, CA. Get the latest business insights from Dun & Bradstreet.See details»

3T Biosciences Inc. - life-sciences-usa.com

Feb 4, 2021 3T Biosciences is an immunotherapy company focused on discovering and developing next-generation therapies with curative potential based on its immune-response โ€ฆSee details»

Second cancer immunotherapy partnership with 3T Bio

Jan 4, 2024 Based in South San Francisco, 3T Biosciences is led by an experienced management team and supported by top investors including Westlake Village BioPartners, โ€ฆSee details»

Why 3T Biosciences is working with โ€ฆ

Jan 11, 2023 The TRACE platform draws from diverse target libraries and uses machine learning algorithms to identify TCR targets. Under the terms of the agreement, Boehringer โ€ฆSee details»

3T Biosciences Company Information - Funding, Investors, and More

Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»

3T Biosciences - VentureRadar

"3T Biosciences is an immunotherapy company based in South San Francisco. The companyโ€™s 3T-TRACE technology applies a yeast display platform and active machine learning to identify โ€ฆSee details»

3T Biosciences, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Boehringer has been on something on a deal-making spree to swell out its pipeline this year. Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical โ€ฆSee details»

3T Biosciences, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for 3T Biosciences, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โ€ฆSee details»

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop โ€ฆ

Jan 9, 2023 INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., USA, 9 January 2023 โ€“ Boehringer Ingelheim and 3T Biosciences, today announced they have entered into a โ€ฆSee details»

3T Biosciences - PitchBook

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; EP-4519675-A1: T-cell target discovery: Pending: 03-May-2022: US-20230227780-A1See details»

Boehringer Ingelheim and 3T Biosciences enter into a second โ€ฆ

Jan 4, 2024 INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ -- Boehringer Ingelheim and 3T Biosciences ("3T") today announced they have โ€ฆSee details»

Boehringer Ingelheim, 3T Biosciences Join Forces to Develop Next ...

Jan 13, 2023 Boehringer Ingelheim and 3T Biosciences announced on Jan. 13, 2023 that they have entered into a strategic collaboration and licensing agreement to discover and develop โ€ฆSee details»

Science - 3T Biosciences

USING COMPUTATION TO ACCELERATE DRUG DISCOVERY AND DEVELOPMENT 3T Biosciences is a data-science driven company. Our core computational expertise includes โ€ฆSee details»

3T Biosciences Builds Transatlantic Pan-Cancer Research

Mar 7, 2024 3T Biosciences today announced that it has entered into multiple additional collaborations with leading academic centers and principal investigators to further fuel 3T's โ€ฆSee details»

Join us April 1 for the 2025 3MT finals event

Mar 24, 2025 She previously achieved a Master of Science in Materials Engineering and worked several years as a full-time researcher at National Building Research Organization in Sri โ€ฆSee details»

linkstock.net © 2022. All rights reserved